Scott L Burrows Aeglea Bio Therapeutics, Inc. (AGLE) insider trading activity

AGLE Quotes by TradingView

Scott L Burrows is Chief Financial Officer of Aeglea BioTherapeutics, Inc.. Currently has a direct ownership of 116,422 shares of AGLE, which is worth approximately $3.22 Million. The most recent transaction as insider was on Sep 03, 2024, when has been sold 18,531 shares (Common Stock) at a price of $28.17 per share, resulting in proceeds of $522,018. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 116K
13.73% 3M change
n/a 12M change
Total Value Held $3.22 Million

Scott L Burrows Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2024
SELL
Open market or private sale
$522,018 $28.17 p/Share
18,531 Reduced 13.73%
116,422 Common Stock
Dec 22 2023
BUY
Grant, award, or other acquisition
-
134,953 Added 50.0%
134,953 Common Stock

Also insider at

ARQT
Arcutis Biotherapeutics, Inc. Healthcare
Chief Financial Officer
SLB

Scott L Burrows

Chief Financial Officer
Westlake Village, CA

Track Institutional and Insider Activities on AGLE

Follow Aeglea BioTherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGLE shares.

Notify only if

Insider Trading

Get notified when an Aeglea Bio Therapeutics, Inc. insider buys or sells AGLE shares.

Notify only if

News

Receive news related to Aeglea BioTherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGLE